Publications New

May 1, 2021 Diabetologia.

Current and future therapies for type 1 diabetes.

von Scholten BJ, Kreiner FF, Gough SCL, von Herrath M.

May 1, 2021 Genome Res.

Third-generation sequencing revises the molecular karyotype for Toxoplasma gondii and identifies emerging copy number variants in sexual recombinants.

Xia J, Venkat A, Bainbridge RE, Reese ML, Le Roch KG, Ay F, Boyle JP.

May 1, 2021 Immunol Rev.

Classical CD4 T cells as the cornerstone of antimycobacterial immunity.

Morgan J, Muskat K, Tippalagama R, Sette A, Burel J, Lindestam Arlehamn CS.

May 1, 2021 J Allergy Clin Immunol.

PrecISE: precision medicine in severe asthma: An adaptive platform trial with biomarker ascertainment.

Israel E, Denlinger LC, Bacharier LB, LaVange LM, Moore WC, Peters MC, Georas SN, Wright RJ, Mauger DT, Noel P, Akuthota P, Bach J, Bleecker ER, Cardet JC, Carr TF, Castro M, Cinelli A, Comhair SAA, Covar RA, Alexander LC, DiMango EA, Erzurum SC, Fahy JV, Fajt ML, Gaston BM, Hoffman EA, Holguin F, Jackson DJ, Jain S, Jarjour NN, Ji Y, Kenyon NJ, Kosorok MR, Kraft M, Krishnan JA, Kumar R, Liu AH, Liu MC, Ly NP, Marquis MA, Martinez FD, Moy JN, O'Neal WK, Ortega VE, Peden DB, Phipatanakul W, Ross K, Smith LJ, Szefler SJ, Teague WG, Tulchinsky AF, Vijayanand P, Wechsler ME, Wenzel SE, White SR, Zeki AA, Ivanova A.

May 1, 2021 Mucosal Immunol.

Metabolic activation and colitis pathogenesis is prevented by lymphotoxin β receptor expression in neutrophils.

Riffelmacher T, Giles DA, Zahner S, Dicker M, Andreyev AY, McArdle S, Perez-Jeldres T, van der Gracht E, Murray MP, Hartmann N, Tumanov AV, Kronenberg M.

Apr 28, 2021 Open Forum Infect Dis.

The longest persistence of viable SARS-CoV-2 with Recurrence of viremia and relapsing symptomatic COVID-19 in an immunocompromised patient-a case study.

Sepulcri C, Dentone C, Mikulska M, Bruzzone B, Lai A, Fenoglio D, Bozzano F, Bergna A, Parodi A, Altosole T, Delfino E, Bartalucci G, Orsi A, Di Biagio A, Zehender G, Ballerini F, Bonora S, Sette A, De Palma R, Silvestri G, De Maria A, Bassetti M.

Apr 23, 2021 Vaccines (Basel).

Balanced cellular and humoral immune responses targeting multiple antigens in adult receiving a quadrivalent inactivated influenza vaccine.

Yu ED, Grifoni A, Sutherland A, Voic H, Wang E, Frazier A, Jimenez-Truque N, Yoder S, Welsh S, Wooden S, Koff W, Creech B, Sette A, da Silva Antunes R.

Apr 13, 2021 Cell Rep.

Cellular mRNA triggers structural transformation of Ebola virus matrix protein VP40 to its essential regulatory form.

Landeras-Bueno S, Wasserman H, Oliveira G, VanAernum Z, Busch F, Salie ZL, Wysocki VH, Andersen K, Saphire EO.

Apr 13, 2021 Immunity.

A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus.

Gunn BM, Lu R, Slein MD, Ilinykh PA, Huang K, Atyeao C, Shcendel SL, Kim J, Cain C, Roy V, Suscovich TJ, Takada A, Halfmann PJ, Kawaoka Y, Pauthner MG, Momoh M, Goba A, Kanneh L, Andersen KG, Schieffelin JS, Grant D, Garry RF, Saphire EO, Bukreyev A, Alter G.

Apr 8, 2021 JCI Insight.

A system-view of Bordetella pertussis booster vaccination responses in adults primed with whole-cell versus acellular vaccine in infancy.

da Silva Antunes R, Soldevila F, Pomaznoy M, Babor M, Bennett J, Tian Y, Khalil NN, Qian Y, Mandava A, Scheuermann RH, Cortese M, Pulendran B, Petro CD, Gilkes AP, Purcell LA, Sette A, Peters B.

Apr 6, 2021 Nat Commun.

T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

Ogbe A, Kronsteiner B, Skelly DT, Pace M, Brown A, Adland E, Adair K, Akhter HD, Ali M, Ali SE, Angyal A, Ansari MA, Arancibia-Cárcamo CV, Brown H, Chinnakannan S, Conlon C, de Lara C, de Silva T, Dold C, Dong T, Donnison T, Eyre D, Flaxman A, Fletcher H, Gardner J, Grist JT, Hackstein CP, Jaruthamsophon K, Jeffery K, Lambe T, Lee L, Li W, Lim N, Matthews PC, Mentzer AJ, Moore SC, Naisbitt DJ, Ogese M, Ogg G, Openshaw P, Pirmohamed M, Pollard AJ, Ramamurthy N, Rongkard P, Rowland-Jones S, Sampson O, Screaton G, Sette A, Stafford L, Thompson C, Thomson PJ, Thwaites R, Vieira V, Weiskopf D, Zacharopoulou P, Oxford Immunology Network Covid-19 Response T Cell Consortium, Oxford Protective T Cell Immunology for COVID-19 (OPTIC) Clinical Team, Turtle L, Klenerman P, Goulder P, Frater J, Barnes E, Dunachie S.

Apr 1, 2021 Lancet Respir Med.

Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial.

Day TA, Penn-Nicholson A, Luabeya AKK, Fiore-Gartland A, Du Plessis N, Loxton AG, Vergara J, Rolf TA, Reid TD, Toefy A, Shenje J, Geldenhuys H, Tameris M, Mabwe S, Bilek N, Bekker LG, Diacon A, Walzl G, Ashman J, Frevol A, Sagawa ZK, Lindestam Arlehamn C, Sette A, Reed SG, Coler RN, Scriba TJ, Hatherill M, TBVPX-203 study team.